CORE Industrial Partners Invests in Edwards Moving & Rigging for Heavy Hauling and Rigging Services

CORE Industrial Partners has invested in Edwards Moving & Rigging, a provider of heavy hauling and rigging services to various end markets. Edwards offers turnkey project management and engineering solutions and operates from five facilities across the US. CORE aims to build on Edwards' legacy and support future growth through strategic initiatives and complementary acquisitions.

Edwards Lifesciences (EW) has executed a significant accelerated share repurchase (ASR) program, reflecting its strong financial position and strategic capital allocation. The company, which dominates 60% of the Transcatheter Aortic Valve Replacement (TAVR) market, has executed a $500 million ASR using $3 billion in cash reserves, reducing shares by approximately 5 million while maintaining a 4.68 current ratio [1].

The ASR is part of Edwards' broader capital allocation strategy, which includes substantial investments in research and development (R&D) and acquisitions aimed at reinforcing its leadership in structural heart therapies. The company's dominance in TAVR and Transcatheter Mitral and Tricuspid Therapies (TMTT) segments, which grew by 61.9% year-over-year, underscores its innovation-driven approach [1].

Edwards' strategic capital allocation extends beyond buybacks. The company is investing heavily in R&D and has made strategic acquisitions, such as JenaValve Technology and Endotronix in September 2024, to strengthen its portfolio in transcatheter valve and hemodynamic monitoring technologies [1]. These investments position Edwards to capture the growth potential in the structural heart therapies sector, which is projected to grow at a 13.5% compound annual rate (CAGR) through 2033 [1].

The structural heart therapies market is propelled by several macroeconomic and demographic trends, including an aging population, rising prevalence of cardiovascular diseases, and the shift toward minimally invasive procedures. Edwards' leadership in TAVR and TMTT positions it to capture a disproportionate share of this growth, with the U.S. structural heart imaging market expected to grow at a 5.9% CAGR through 2030 [1].

CORE Industrial Partners' investment in Edwards Moving & Rigging, a provider of heavy hauling and rigging services, aligns with Edwards' focus on turnkey project management and engineering solutions. CORE aims to build on Edwards' legacy and support future growth through strategic initiatives and complementary acquisitions, further enhancing Edwards' operational capabilities [1].

In conclusion, Edwards Lifesciences' strategic capital allocation, aggressive buybacks, and leadership in structural heart innovation position it as a compelling investment opportunity. The company's strong balance sheet, robust pipeline, and clear path to sustained earnings per share (EPS) growth make it well-positioned to deliver outsized returns in the coming years. Investors seeking exposure to a high-growth sector with a company that excels in both financial and operational execution should consider Edwards as a rare and compelling opportunity.

References:
[1] https://www.ainvest.com/news/edwards-lifesciences-aggressive-buybacks-strategic-capital-allocation-high-growth-sector-2508/